Article Menu
Need Help?
No Article Versions Notes Found
Cite
Melosky, B.; Burkes, R.; Rayson, D.; Alcindor, T.; Shear, N.; Lacouture, M. Management of Skin Rash during egfr-Targeted Monoclonal Antibody Treatment for Gastrointestinal Malignancies: Canadian Recommendations. Curr. Oncol. 2009, 16, 16-26. https://doi.org/10.3747/co.v16i1.361
Melosky B, Burkes R, Rayson D, Alcindor T, Shear N, Lacouture M. Management of Skin Rash during egfr-Targeted Monoclonal Antibody Treatment for Gastrointestinal Malignancies: Canadian Recommendations. Current Oncology. 2009; 16(1):16-26. https://doi.org/10.3747/co.v16i1.361
Chicago/Turabian StyleMelosky, Barbara, R. Burkes, D. Rayson, T. Alcindor, N. Shear, and M. Lacouture. 2009. "Management of Skin Rash during egfr-Targeted Monoclonal Antibody Treatment for Gastrointestinal Malignancies: Canadian Recommendations" Current Oncology 16, no. 1: 16-26. https://doi.org/10.3747/co.v16i1.361
APA StyleMelosky, B., Burkes, R., Rayson, D., Alcindor, T., Shear, N., & Lacouture, M. (2009). Management of Skin Rash during egfr-Targeted Monoclonal Antibody Treatment for Gastrointestinal Malignancies: Canadian Recommendations. Current Oncology, 16(1), 16-26. https://doi.org/10.3747/co.v16i1.361
